Zobrazeno 1 - 3
of 3
pro vyhledávání: '"Amelia Béjar"'
Publikováno v:
World Journal of Clinical Oncology
Technological advances in radiotherapy have led to the introduction of techniques such as stereotactic body radiation therapy (SBRT), allowing the administration of ablative doses. The hypothesis that oligometastatic disease may be cured through loca
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c064c09fd3fa44421e3057f9f336e125
https://doi.org/10.5306/wjco.v10.i2.38
https://doi.org/10.5306/wjco.v10.i2.38
Autor:
Víctor Zamora, Olatz Garin, Yolanda Pardo, Àngels Pont, Cristina Gutiérrez, Patricia Cabrera, Francisco Gómez-Veiga, José Ignacio Pijoan, Mark S. Litwin, Montse Ferrer, Montse Ventura, Ferran Guedea, Ferran Ferrer, Ana Boladeras, Andrea Slocker, José Francisco Suárez, Manuel Castells, Xavier Bonet, David B. Delgado, MaJosé Ortiz, Ismael Herruzo, José López-Torrecilla, Jorge Pastor, Víctor Muñoz, Patricia Willsich, Marisa Vázquez, Àlvar Roselló, Arantxa Eraso, Carlos Ferrer, Ángel Sánchez, Víctor Macías, Lluís Fumadó, Josep Jové, Moisés Mira, Elena Villafranca, Juan Morote, Ana Celma, Pilar Samper, Luís A. Glaría, MaÁngeles Cabeza, Germán Juan, Samuel Méndez Ramírez, Amalia Palacios, Amelia Béjar, Sonia Garcia, Sebastà Sabater
Objectives This study aimed to develop mapping algorithms from the Expanded Prostate Cancer Index Composite (EPIC) and the Short-Form (SF) Health Surveys to the Patient-Oriented Prostate Utility Scale (PORPUS), an econometric instrument specifically
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6724b10165bf4a9ffe15a2c58a817599
http://hdl.handle.net/10230/53731
http://hdl.handle.net/10230/53731
Autor:
Amelia Béjar, Felipe A. Calvo, Francisco Valcárcel, Rosa Algás, Almudena Zapatero, Salvador Villà, Javier Maldonado
Publikováno v:
Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 23(27)
Purpose Multicenter study conducted to determine the impact on biochemical control and survival of risk-adapted androgen deprivation (AD) combined with high-dose three-dimensional conformal radiotherapy (3DCRT) for prostate cancer. Results of biochem
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a2e28a59f78f44f523044ee1335790b1
https://pubmed.ncbi.nlm.nih.gov/16170164
https://pubmed.ncbi.nlm.nih.gov/16170164